Article
The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.
The Prostate
(2008)
Disciplines
Publication Date
December 1, 2008
DOI
10.1002/PROS.20842
Citation Information
John K. Scariano, Eric Treat, Frances Alba, Harold Nelson, et al.. "The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer." The Prostate Vol. 68 Iss. 16 (2008) p. 1798 - 1805 Available at: http://works.bepress.com/eric-treat/17/